GA
SRCL

Geneva Advisors’s Stericycle Inc SRCL Stock Holding History

Geneva Advisors’s Portfolio SRCL Stock Details SRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.52M Sell
32,959
-1,200
-4% -$98.6K 0.04% 178
2017
Q1 		$2.83M Sell
34,159
-3,077
-8% -$247K 0.05% 171
2016
Q4 		$2.87M Sell
37,236
-2,121
-5% -$160K 0.06% 167
2016
Q3 		$3.15M Sell
39,357
-5,764
-13% -$521K 0.06% 152
2016
Q2 		$4.7M Sell
45,121
-9,213
-17% -$986K 0.09% 120
2016
Q1 		$6.86M Sell
54,334
-45,635
-46% -$5.32M 0.14% 98
2015
Q4 		$12.1M Sell
99,969
-3,482
-3% -$444K 0.23% 84
2015
Q3 		$14.4M Sell
103,451
-210,174
-67% -$29.3M 0.29% 85
2015
Q2 		$42M Sell
313,625
-71,338
-19% -$9.78M 0.75% 48
2015
Q1 		$54.1M Sell
384,963
-4,933
-1% -$666K 0.98% 36
2014
Q4 		$51.1M Sell
389,896
-12,593
-3% -$1.59M 0.95% 39
2014
Q3 		$46.9M Sell
402,489
-71,256
-15% -$8.42M 0.88% 47
2014
Q2 		$56.1M Sell
473,745
-46,005
-9% -$5.27M 1.02% 35
2014
Q1 		$59.1M Sell
519,750
-136,902
-21% -$15.8M 1.09% 36
2013
Q4 		$76.3M Buy
656,652
+11,341
+2% +$1.32M 1.41% 23
2013
Q3 		$74.5M Buy
645,311
+423
+0.1% +$48.8K 1.55% 20
2013
Q2 		$71.2M Buy
+644,888
New +$70.1M 1.66% 14

Other funds holding SRCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geneva Advisors's SRCL Position: Q2 2017 in Review

Geneva Advisors reduced its Stericycle Inc (SRCL) stake by 3.5% in Q2 2017, selling an estimated $98.6K and leaving 32,959 shares worth $2.52M. The position accounts for 0.04% of the portfolio, ranked #178.

Geneva Advisors first reported a position in SRCL in Q2 2013 and has held it in 17 quarters since. The position peaked at $76.3M in Q4 2013. 550 funds tracked by Wall St. Rank hold SRCL as of Q2 2017.

  • Geneva Advisors held 32,959 shares of Stericycle Inc worth $2.52M as of Q2 2017.
  • Geneva Advisors sold 1,200 Stericycle Inc shares in Q2 2017, an estimated $98.6K.
  • Stericycle Inc made up 0.04% of Geneva Advisors's portfolio in Q2 2017, its #178 holding.
  • Geneva Advisors first reported a position in Stericycle Inc in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Stericycle Inc position peaked at $76.3M in Q4 2013.
  • 550 funds tracked by Wall St. Rank held Stericycle Inc as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.